Formulate

Find pharma jobs. Prep for interviews like no one else can.

Browse

Jobs Companies Drugs Indications Career Advisor About

Insider Intel

Intelligence Hub Therapeutic Areas Contribute Intro Network Salary Explorer For Employers

Legal

argenx Jobs | Formulate

Jobs
argenx

argenx Jobs

Belgium - Zwijnaarde

Biotechnology

argenx is a life sciences company focused on Antibody therapies.

48 open positions at argenx

View Full Profile

Executive Assistant

argenx

Posted 3w ago

Boston, MA, USA

$76K - $105K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Head of U.S. Regulatory Advertising & Promotion and Strategic Commercialization

argenx

Posted 4w ago

Remote

$268K - $369K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteRegulatory AffairsImmunologyExecutive

H-1B · 1 FY23

Territory Business Manager, Louisville

argenx

Posted 1mo ago

United States - Field; Lexington

$140K - $193K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

CommercialNeurologyMANAGER

H-1B · 1 FY23

Director, US Patient Assistance Program

argenx

Posted 1mo ago

Remote

$184K - $253K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologyExecutive

H-1B · 1 FY23

Associate Director, HCP Marketing

argenx

Posted 1mo ago

Remote

$168K - $231K

Full-time

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteCommercialImmunologyExecutive

H-1B · 1 FY23

Director, Global Indication Lead, Rheumatology

argenx

Posted 1mo ago

Boston, MA, USA

$196K - $270K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologyExecutive

H-1B · 1 FY23

Finance Business Partner R&D

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologyMID

H-1B · 1 FY23

Key Account Manager (m/w/d) – Rare Disease (Nord/West) | Gebiet eigenständig führen

argenx

Posted 1mo ago

Germany - Field

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

CommercialRare DiseaseMANAGER

H-1B · 1 FY23

Principal Scientist Bioanalytics

argenx

Posted 1mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologySenior

H-1B · 1 FY23

Head of Product Quality Manufacturing and Testing

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ManufacturingImmunologyExecutive

H-1B · 1 FY23

Director, US Compliance

argenx

Posted 2mo ago

Boston, MA, USA

$204K - $281K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

LegalImmunologyExecutive

H-1B · 1 FY23

Corporate Counsel

argenx

Posted 2mo ago

Remote

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologyMID

H-1B · 1 FY23

Biomarker Biostatistics Lead

argenx

Posted 2mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Data ScienceImmunologySenior

H-1B · 1 FY23

Senior Safety Medical Evidence & Insights Lead

argenx

Posted 3mo ago

Remote

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Director of Medical Writing

argenx

Posted 3mo ago

Remote

$212K - $292K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteMedical WritingImmunologyExecutive

H-1B · 1 FY23

Global FP&A Operations Lead

argenx

Posted 3mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

FinanceImmunologySenior

H-1B · 1 FY23

Reporting & Insights Lead

argenx

Posted 3mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

ImmunologySenior

H-1B · 1 FY23

Sr Manager, Medical Review Operations

argenx

Posted 3mo ago

Remote

$140K - $193K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Senior Scientist CMC

argenx

Posted 3mo ago

Gent, Belgium

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

Research & DevelopmentImmunologySenior

H-1B · 1 FY23

Medical Safety Lead

argenx

Posted 3mo ago

Remote

$292K - $402K

Full-time

Related drug: VYVGART

Condition in scope: Neonatal Presentation (First 28 Days of Life)

RemoteImmunologySenior

H-1B · 1 FY23

Company Overview

Active Jobs

Pipeline Programs

Drug Products

Clinical Trials

View Full Company Profile

Therapeutic Areas

Neurology Immunology Oncology

Links

Company Website Careers Page

Hematology

Rare Diseases